E
Sammendrag av Paulings praktiske anvisninger på å ta vitamin C
1.
Når man er frisk
1.1 Hva bør man velge å ta:
Askorbinsyre eller natriumaskorbat?
Som vitamin C velger man her i
landet i praksis mellom askorbinsyre (E 300) og natriumaskorbat (E 301). (Selv
om kalsiumaskorbat, E 302 også selges er prisen i apotekene 3,8 ganger så høy
som for natriumaskorbat.)
Noen mener at de tåler
natriumaskorbat bedre enn askorbinsyre. (NB: Askorbinsyre skaper ikke magesår.
Magesyren er en sterk syre, og askorbinsyre øker ikke dens surhet.) For
enkelte er en blanding av askorbinsyre og natriumaskorbat det som bekommer dem
best, for eksempel 50/50. Vær klar over at E 301 er lang mer lettoppløselig
enn E 300, og det er jo en fordel.
Hva angår nyresten,
er det 2 typer. Den ene typen dannes i alkalisk urin, og består av
kalsiumfosfat, magnesium ammonium fosfat, kalsium karbonat, eller blandinger
av disse stoffene. Den beste måten å gjøre urinen surere på er å ta askorbinsyre
som vitamin C. –Den andre typen nyresten som har en tendens til å bli
dannet i sur urin, består av kalsium oksalat, urinsyre eller cystin. Personer
med slik urin bør ta natriumaskorbat
som vitamin C.
Ta ren, krystallinsk
vitamin C, uansett om du velger E 300 eller E 301. Det er langt billigere enn
tabletter (en strøken standard teskje = ca. 3.000 mg koster ca. 1,20 kr/dag),
medfører ikke at man får i seg store mengder fyllstoffer fra tablettene, og
er et beskjedent volum å konsumere.
1.2 Hvor meget bør man ta?
Vær
klar over at du i den første uken lettere får løs avføring enn senere,
alle andre forhold tatt konstant. Dette er en overgang.
Start
med 1.000 mg eller 2.000 mg oppløst i veske, for eksempel i appelsinjuice,
melk, Farris eller annet som passer for den enkelte. Øk dags-inntaket etter
hvert til du får en løs, vandig avføring. (Dette er din
magetoleranse-grense). Reduser inntaket litt etterfølgende dag hvis avføringen
er like tynn. Ta vitamin C om morgenen, gjerne etter måltidet. Det riktige
kvantum for deg er når du får en avføring som kommer naturlig etter
frokost.
1.3 Kan man hoppe over 1 eller
flere dager?
Det er viktig at tilførselen
av store mengder vitamin C ikke utelates selv en enkelt dag. Det er en
tilbakeslagseffekt når C vitamintilførselen utelates, hvilket fører til økt
sykdomsrisiko. (En langsom nedtrapping gir ikke denne tilbakeslagseffekten.
Les mer om dette i punkt 5.5 på side 17.)
2.
Når man har symptomer på
sykdom
2.1 Nødvendig
kvantum ved virusangrep
Vitamin C har liten effekt ved akutte symptomer før man kommer opp
i doser tilsvarende 80 til 90% av magetoleransen. Den økes vesentlig ved
virusangrep (og bakterieangrep).
2.2 Nødvendig kvantum ved forkjølelsesangrep
Ta 1.500 til 2.000 mg vitamin
C ved første tegn på forkjølelse, og gjenta dosen hvert 20. til 30.
minutt til symptomene er blitt borte; hvilket vanligvis skjer ved 3. dose.
2.3 Nødvendig
kvantum ved kreft m.m.
Det vises til hovedavsnitt D, pkt. 9.2 til 10.7.
Kildefortegnelse
1.
”Nordiska näringsrekommendationer 1996”. (I utredningen omtalt som NNR.) Rapport
utarbeidet av Brittmarie Sandstrøm, Antti Aro, Wulf Becker, Niels Lyhne, Jan
I. Pedersen og Inga Þórsdóttir. En arbetsgrupp tillsatt av Äk-LIVS,
Nordisk Ministerråd. Nord 1996:28. København 1996. ISBN 92-9120-930-9.
2.
Gunn-Elin
Aa. Bjørneboe og Christian A. Drevon: ”Mat og medisin. Nordisk lærebok i
generell og klinisk ernæring.” 4. utgave. Høyskoleforlaget AS,
Kristiansand 1999. ISBN 82-7634-241-8.
3.
Jan I.
Pedersen, Mari Nes, Hanne Müller og Andrée Levorsen: ”Ernæringslære”.4.
utgave. Landsforeningen for kosthold og helse, Oslo juli 1998. ISBN 82-7047-071-6.
4.
Subcommittee
on the Tenth Edition of the RDA’ Food and Nutrition Board. Commission on the
Life Sciences, National Research Council: ”Recommended Dietary Allowances”.
10. utgave. National Academy Press, Washington D.C. 1989. ISBN 0-309-04041-8.
5.
Terence
W. Anderson: ”Large-scale trials of vitamin C”. Annals of the New York
Academy of Sciences, bind 258, side 498 – 504, 30.9.1975. ISBN
0-89072-011-8.
6.
H.
Howald, B. Segesser og W.F.Korner: ”Ascorbic acid and athletic performance”.
Annals of the New York Academy of Sciences, bind 258, side 458 – 464,
30.9.1975.
ISBN 0-89072-011-8.
7.
Alfred
E. Harper: ”The recommended dietary allowances for ascorbic acid”. Annals
of the New York Academy of Sciences, bind 258, side 491 – 497, 30.9.1975.
ISBN 0-89072-011-8.
8.
Thomas
H. Jukes: ”Are Recommended Daily Allowances for Vitamin C Adequate?”
Proceedings of the National Academy of Sciences, bind 71, nr. 5, side 1949 –
1951. Mai 1974.
9.
Maurice
E. Shils, James A. Olson, Moshe Shike og A. Catharine Ross: ”Modern
Nutrition in Health and Disease”. 8. utgave, Baltimore, Maryland 1994, side
467 – 483. ISBN 0-683-30769-X.
10.
Linus
Pauling: ”How to live longer and feel better”. Avon Books, Inc., New York
1986. ISBN 0-380-70289-4.
11.
D.W.Cowan,
H.S.Diehl og A.B.Baker: ”Vitamins for the Prevention of Colds”. Journal of
the American Medical Assosiation 120: 1268-1271. Artikkelen
ble publisert i 1942.
12.
Irving
Stone: ”Studies of a Mammalian Enzyme System for Producing Evolutionary
Evidence on Man”. American Journal of Physical Antrthropology 23: 83-86. Artikkelen
ble publisert i 1965.
13.
P.L.Altman og D.S.Dittmer: ”Metabolism”.
Federation
of American Societies for Experimental Biology. Bethesda, Md., 1968.
14.
R.Myllylä,
K.Majamaa, V.Gunzler, H.M.Hanuska-Abel og K.I.Kivirikko:”Ascorbate Is
Consumed Stoichiometrically in the Uncoupled Reactions Catalyzed by
Prolyl-4-Hydroxylase and Lysyl Hydroxylase”. Journal of Biological Chemistry
259:5403-5405. 1984.
15.
G.H.Bourne: ”Vitamin C and Immunity”. British Journal
of Nutrition 2: 346-356. 1949.
16.
I Stone: ”The Genetic Disease Hypoascorbemia”. Acta Geneticae Medicae et Gemellologiae 16: 52-60. 1967.
17.
L.L.Salomon
og S.W.Stubbs: ”Some Aspects of the Metabolism of Ascorbic Acid in Rats”.
Annals of the New York Academy of Sciences 92: 128-140. 1961.
18.
I.B.Chatterjee,
A.K.Majumder, B.K.Nandi og N.Subramanian: ”Synthesis and Some Major
Functions of Vitamin C in Animals”. Annals of the New York Academy of
Sciences 258: 24-47. 1975.
19.
J.F.Rinehart
og L.D.Greenberg: ”Vitamin B6 Deficiency in the Rhesus Monkey with
Particular Reference to the Occurrence of Atherosclerosis, Dental Caries and
Hepatic Cirrhosis”. American Journal of Clinical Nutrition 4: 318-327. 1956.
20.
O.W.Portman,
M.Alexander og C.A.Maruffo: ”Nutritional Control of Arterial Lipid
Composition in Squirrel Monkeys”. Journal of Nutrition 91: 35-44. 1967.
21.
M.S.Yew:
”Recommended Daily Allowances for Vitamin C”. Proceedings of the National
Academy of Sciences USA 70: 969-972. 1973.
22.
F.R.Klenner:
”Observations on the Dose and Administration of Ascorbic Acid When employed
beyond the Range of a Vitamin in Human Pathology”. Journal of Applied
Nutrition 23: 61-88. 1971.
23.
M.Virno,
M.G.Bucci, J.Pecori-Giraldi og A.Missiroli: ”Oral Treatment of Glaucoma with
Vitamin C”. The Eye, Ear, Nose and Throat Monthly 46: 1502-1508. 1967.
24.
G.B.Bietti:
”Further Contributions on the Value of Osmotic Substances as Means to Reduce
Intra-Ocular Pressure”. Ophthalmological Society of Australia 26: 61-71.
1967.
25.
M.Herjanic
og B.L.Moss-Herjanic: ”Ascorbic Acid Test in Psychiatric Patients”.
Journal of Schizophrenia 1: 257-260. 1967.
26.
H.D.Chope
og L.Breslow: ”Nutritional Status of the Aging”. American Journal of
Public Health 46: 61-67. 1955.
27.
W.Kubler
og J.Gehler: ”Zur Kinetik der enteralen Ascorbinsäuereressorption zur Berechnung nicht dosisproportionaler Reseptionsvorgänge”.
Internationale Zeitschrift für Vitaminforschung 40 442-453. 1970.
28.
A.Harris, A.B.Robinson og L.Pauling: ”Blood Plasma
L-Ascorbic Acid Consentration for Oral L-Ascorbic Acid Dosage up to 12 Grams
per Day”. International Research Communications System, page 19, December
1973.
29.
J.J.DeCosse, M.B.Adams, J.F.Kuzma, P.Lo Gerfo
ogR.E.Condon: ”Effect of Ascorbic on Rectal Polyps of Patients with Familial
Polyposis”. Surgery 78: 608-612. 1975.
30.
G.J.Friedman,
S.Sherry og E.P.Ralli: ”Mechanism of Excretion of Vitamin C by Human Kidney
at Low and Normal Plasma Levels of Ascorbic Acid”. Journal of Clinical
Investigations 19: 685-689. 1940.
31.
L.J.Harris
og S.N.Ray: ”Diagnosis of Vitamin C-Subnutrition by Urinalysis with Note on
Antiscorbutic Value of Human Milk”. The Lancet 1: 71-77. 1935.
32.
D.Hawkins
og L.Pauling: ”Orthomolecular Psychiatry”. W.H.Freeman and Co., San
Fransisco 1973.
33.
J.F.Dice
og C.W.Daniel: ”The Hypoglycemic Effect of Ascorbic Acid in Juvenile-onset
Diabetic”. International Research Communications System 1:41. 1973.
34.
S.Vallance:
”Relationships between Ascorbic Acid and Serum Proteins of the Immune
System”. British Medical Journal 2 : 437-438. 1977.
35.
W.Prinz,
R.Bortz, B.Bragin og M.Hersch: ”The Effect of Ascorbic Acid Supplementation
on Some Parameters of the Human Immunological Defence System”. International
Journal of Vitamin and Nutrition Research 47: 248-256. 1977.
36.
R.H.Yonemoto,
P.B.Chretien og T.F.Fehniger: ”Enhanced Lymphocyte Blastogenesis by Oral
Ascorbic Acid”. Proceedings of the American Association of Cancer Research
17:288. 1976.
37.
R.H.Yonemoto:
”Vitamin C and the Immunological Response in Normal Controls and in Cancer
Patients (portugisisk)”. Medico Dialogo 5: 23:30. 1979.
38.
R.Anderson:
”Ascorbate-Mediated Stimulation of Neutrophil Motility and Lymphocyte
Transformation by Inhibition of the Peroxidase-H2O2-Halide
System in Vitro and in Vivo”. American Journal of Clinical Nutrition 34:
1906-1911. 1981.
39.
R.Anderson:
”Effects of Ascorbate on Normal and Abnormal Leukocyte Functions, in Vitamin
C”. New Clinical Applications in Immunology, Lipid Metabolism, and Cancer. Utgitt
av A.Hanck, Hans Huber, Bern, side 23-34. 1982.
40.
R.S.Panush,
J.C.Delafuente, P.Katz og J. Johnson: ”Modulation of Certain Immunologic
Responses by Vitamin C. III. Potentiation of In Vitro and In Vivo Lymphcyte
Responses, in Vitamin C”. New Clinical Applications in Immunology, Lipid
Metabolism, and Cancer. Utgitt av A.Hanck, Hans Huber,
Bern, side 35-47. 1982.
41.
E.Cottingham
og C.A.Mills: ”Influence of Temperature and Vitamin Deficiency upon
Phagocytic Functions”. Journal of Immunology 47: 493-502. 1943.
42.
R.Hume
og E.Weyers: ”Changes in Leucocyte Ascorbic Acid during the Common Cold”.
Scottish Medical Journal 18: 3-7. 1973.
43.
I.Stone:
”The Healing Factor: Vitamin C against Disease”. Grosset and Dunlap, New
York, 1972.
44.
L.Pauling:
”Vitamin C and the Common Cold”. W.H.Freeman, San Fransisco, 1970.
45.
D.F.Horrobin,
M.Oka og M.S.Manku: ”The Regulation of Prostagladin E1 Formation: A
Candidate for One of the Fundamental Mechanisms Involved in the Actions of
Vitamin C”. Medical Hypotheses 5: 849-858. 1979.
46.
R.Korbsch:
”Cevitamin Acid Therapy of Allergic Inflammatory Conditions”. Medizinische
Klinik 34: 1500-1505. 1938.
47.
A.J.Glazebrook
og S.Thomson: ”The Administration of Vitamin C in a Large Institution and
Its Effect on General Health and Resistance to Infection”. Journal of
Hygiene 42: 1-19. 1942.
48.
G.Ritzel:
”Kritische Beurteiligung des Vitamins C als Prophylacticum und Therapeuticum
der Erkältigungskrankheiten”. Helvetica Medica Acta 28: 63-68.
1961.
49.
T.W.Anderson,
D.B.W.Reid og G.H.Beaton: ”Vitamin C and the Common cold: A Double Blind
Trial”. Canadian Medical Association Journal 107: 503-508. 1972.
50.
B.H.Sabiston
og N.W.Radomski: ”Health Problems and Vitamin C in Canadian Norhern Military
Operations”. Defence and Civil Institute of Environmental Medicine Report
No. 74-R-1012. 1974.
51.
P.E.Barnes
Jr.: ”Vitamin Supplements and the Incidence of Colds in High School
Basketball Players”. North Carolina Medical Journal 22: 22-26. 1961.
52.
H.S.Banks:
”Common Cold: Controlled Trials”. The Lancet 2: 790. 1965.
53.
H.S.Banks:
”Controlled Trials in the Early Antibiotic Treatment of Colds”. The
Medical Officer 119: 7-10. 1968.
54.
N.W.Markwell:
”Vitamin C in the Prevention of Colds”. Medical Journal of Australia 2:
777-778. 1947.
55.
E.Regnier:
”The Administration of Large Doses of Ascorbic Acid in the Prevention and
Treatment of the Common Cold, Parts I and II”. Review of Allergy 22:
835-846, 948-956. 1968.
56.
D.W.Cowan
og H.S.Diehl: ”Antihistamine Agents and Ascorbic Acid inthe Early Treatment
of the Common Cold”. Journal of the American Medical Association 143:
421-424. 1950.
57.
J.Asfora:
”Vitamin C in High Doses in the Treatment of the Common Cold” i
”Re-evaluation of Vitamin C” utgitt av A.Hanck og G.Ritzel, Hans Huber,
Bern, sidene 219-234. 1977. ISBN 3-456-80535-7.
58.
R.F.Cathcart:
”Vitamin C, Titrating to Bowel Tolerance, Anascorbemia, and Acute Induced
Scurvy”. Medical Hypothesis 7: 1359-1376. 1981.
59.
C.W.Jungeblut:
”Inactivation of Poliomyelitis Virus by Crystalline Vitamin C”. Journal of
Experimental Medicine 62: 517-521. 1935.
60.
C.H.Boissevain
og J.H.Spillane: ”Effect of Syntetic Ascorbic Acid on the Growth of
Tuberculosis Bacillus”. American Review of the Tuberculosis 35: 661-662.
1937.
61.
T.E.Miller:
”Killing and Lysis of Gram-Negative Bacteria Through the Synergistic Effect
of Hydrogen Peroxide, Ascorbic Acid and Lysozyme”. Journal of Bacteriology
98: 949-955. 1969.
62.
Y.Ericksson
og H.Lundbeck: ”Antimicrobial Effect in vitro of the Ascorbic Acid Oxidation.
I. Effect on Bacteria, Fungi and Viruses in Pure Culture. II. Influence of
Various Chemical and Physical Factors.” Acta Pathalogica et Microbiologica
Scanidinavica 37: 493-527. 1955.
63.
F.Morishige
og A.Murata: ”Vitamin C for Prophylaxis of Viral Hepatitis B in Transfused
Patients”. Journal of the International Academy of Preventive Medicine 5:
54-58. 1978.
64.
J.H.Crandon,
R.Lennihan Jr, S.Mikal og A.E.Reif: ”Ascorbic Acid Economy in Surgical
Patients”. Annals of the New York Academy of Sciences 92: 246-267. 1961.
65.
T.V.Taylor,
S.Rimmer, B.Day, J.Butcher og I.W.Dymock: ”Ascorbic Acid Supplementation in
the Treatment of Pressure-Sores”. The Lancet, Sept. 7, 1974, sidene 544-546.
66.
P.L.Schwartz:
”Ascorbic Acid in Wound Healing – A Review”. Journal of the American
Dietetic Association 56: 497-503. 1970.
67.
W.M.Ringsdorf
og E.Cheraskin: ”Vitamin C and Human Wound Healing”. Oral Surgery 53:
231-236. 1982.
68.
T.H.Ingalls
og H.A.Warren: ”Asymptotic Scurvy. Its relation to Wound Healing and Its
Incidence in Patients with Peptic Ulcer”. New England Journal of Medicine
217 :443-446. 1937.
69.
B.Portnoy
og J.F.Wilkinson: ”Vitamin C Deficiency in Peptic Ulceration and
Haematemesis”. British Medical Journal 1: 554-560. 1938.
70.
E.Ginter: ”Vitamin C and
Cholesterol” i ”Re-evalutaion of Vitamin C”, utgitt av A.Hanck og
G.Ritzel, Hans Huber, Bern, sidene 53-66. 1977.
71.
H.D.Chope
og L.Breslow: ”Nutritional Status of the Aging”. American Journal of
Public Health 46: 61-67. 1955.
72.
J.E.Enstrom
og L.Pauling: ”Mortality Among Health-Conscious Elderly Californians”.
Proceedings of the National Academy of Sciences USA 79: 6023-6027. 1982.
73.
C.A.B.Clemetson:
”Histamin and Ascorbic Acid i Human Blood”. Journal of Nutrition 110:
662-668. 1980.
74.
E.Zuskin,
A.J.Lewis og A.Bouhuys: ”Inhibition of Histamine-Produced Airway
Constriction by Ascorbic Acid”. Journal of Allergy and Clinical Immunology
51: 218-223. 1973.
75.
F.Valic
og E.Zuskin: ”Pharmacological Prevention of Acute Ventilatory Capasity
Reduction in Flax Dust Exposure”. British Journal of Industrial Medicine 30:
381-384. 1973.
76.
E.Zuskin,
F.Valic og A.Bouhuys: ”Byssinosis and Airway Responses Due to Exposure to
Textile Dust”. Lung 154: 17-21. 1976.
77.
C.O.Anah,
L.N.Jarike og H.A.Baig: ”High Dose Ascorbic Acid in Nigerian Asthmatics”.
Tropical and Geographical Medicine 32: 132-137. 1980.
78.
R.Anderson,
I.Hay, H.van Wyk, R.Oosthuizen og A.Theron: ”The Effect og Ascorbate on
Cellular Humoral Immunity in Asthmatic Children”. South African Medical
Journal 58: 974-977. 1980.
79.
E.Cheraskin,
W.M.Ringsdorf Jr. og E.L.Sisley: ”The Vitamin C Connection”. Harper and
Row, New York, 1983.
80.
G.B.Bietti:
”Further Contributions on the Value of Osmotic Substances as Means to Reduce
Intra-Ocular Pressure”. Ophtalmological Society of Australia 26: 61-71.
1967.
81.
M.Virno,M.G.Bucci,
J.Pecori-Giraldi og A.Missirolli: ”Oral Treatment of Glaucoma with Vitamin
C”. The Eye, Ear, Nose, and Throat Monthly 46: 1502-1508. 1967.
82.
A.Hoffer:
”Ascorbic Acid and Toxity”. New England Journal of Medicine 285: 635-636.
1971.
83.
Ewan
Cameron og Linus Pauling: ”Cancer and Vitamin C”. Philadelphia 1993. ISBN
0-940159-21-x.
84.
James
E. Enstrom, Linda E.Kanim og Morton A.Klein: ”Vitamin C Intake and Mortality
among a Sample of the United States Population”, Epidemiology 3(3): 194-202.
1992.
85.
Abram
Hoffer og Linus Pauling: ”Hardin Jones Biostatistical Analysis of Mortality
Data for Cohorts of Cancer Patients with a Large Fraction Surviving at the
Termination of the Study and a Comparison of Survival Times of Cancer Patients
Receiving Large Regular Oral Doses of Vitamin C and other Nutrients with
Similar Patients Not Receiving Those Doses.” The Journal of Orthomolecular
Medicine 5(3): 143-154. 1990.
86.
J.U.Schlegel:
”Proposed uses of ascorbic acid in prevention of bladder carcinoma”.
Annals of New York Academy of Sciences 258: 432-438. 1975.
87.
J.U.Schlegel,
G.E.Pipkin og L.Banowsky: ”Urine composition in the etiology of bladder
tumor formation”. Journal of Uroology 97: 479-481. 1967.
88.
J.U.Schlegel,
G.E.Pipkin, R.Nishimura og G.A.Duke: ”Studies in the etiology and prevention
of bladder carcinoma”. Journal of Uroology 101: 317-324. 1969.
89.
D.Horrobin,
M.S.Manku, M.Oka, R.O.Morgan, S.C.Cunnane, A.I.Ally, T.Zhayur, M.Schweitzer og
R.A.Karmali: ”The nutritional regulation of T-lymphocyte function”.
Medical Hypotheses 5: 969-985. 1979.
90.
H.A.Pitt
og A.M.Costrini: ”Vitamin C prophylaxis in marine recruits”. Journal of
the American Medical Association 241: 988-1011. 1979.
91.
E.Cameron,
L.Pauling og B.Leibovitz: ”Ascorbic Acid and Cancer: a review”. Cancer
Research 39: 663-681. 1979.
92.
E.Cameron
og A.Campbell: ”The orthomolecular treatment of cancer. II. Clinical trial
of high-dose ascorbic acid supplements in advanced human cancer”. Che.-Biol.
Interact. 9: 285-315. 1974.
93.
E
Cameron og L.Pauling: ”Supplementary ascorbate in the supportive treatment
of cancer; prolongation of survival times in terminal human cancer”.
Proceedings of the National Academy of Sciences, USA 73: 3685-3689. 1976.
94.
E.Cameron
og L.Pauling: ”Supplemental ascorbate in the supportive treatment of cancer:
reevaluation of prolongation of survival times in terminal human cancer”.
Proceedings of the National Academy of Sciences USA 75: 4538-4542. 1978.
95.
E.T.Creagan,
C.G.Moertel, J.R.O’Fallon , A.J.Schutt, M.J.O’Connell, J.Rubin og S.Frytak:
”Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients
with advanced cancer; a controlled trial”.
New England Journal of Medicine 29.9.1979.
96.
J.J.deCosse,
M.B.Adams, J.F.Kuzma, P.LoGerfo og R.E.Condon: ”Effect of ascorbic acid on
rectal polyps of patients with familial polyposis”. Surgery 78: 608-612.
1975.
97.
H-Y.L.Lai,
Eleanor K.Shields og A.L.Watne: ”Effect of ascorbic acid on rectal polyps
and fecal steroids”. Fed.Proc. (Abs.) 35: 1061. 1977.
98.
A.L.Watne, H-Y. Lai, J.Carrier og W.Coppula: ”The diagnosis and
surgical treatment of patients with Gardner’s syndrome”. Surgery 82:
327-333. 1977.
99.
E.Bjelke:
”Epidemiologic studies of cancer of the stomach, colon and rectum”. Doktoravhandling
ved University of Minnesota 1973.
100.
E.Bjelke:
”Epidemiologic studies of cancer of the stomach, colon and rectum with
special emphasis on the role of diet”. The Scandinavian Journal of
Gastroenterology, 9 (Suppl. 31): 1-235. 1974.
101.
E.Cheraskin,
W.M.Ringsdorf Jr., K.Hutchins, A.T.S.H.Setyaadmadja og G.L.Wideman: ”Effect
of diet upon radiation response in cervical carcinoma of the uterus: A
preliminary report”. Acta Cytologica 12: 433-438. 1968.
102.
S.G.Moertel:
”Current concepts in cancer: chemoterapi of gastrointestinal cancer”. The
New England Journal of Medicine 299: 1049-1052. 9.11.1978.
103.
Harri
Hemilä: ”Vitamin C and common cold
incidence: a review of studies with subjects under heavy physical stress”.
International Journal of Sports Medicine 17 (5): 379-383. Juli 1996.
104.
Harri
Hemilä: ”Does vitamin C alleviate the
Symptomes of the common cold? – a review of current evidence”. The
Scandinavian Journal of Infectious Diseases 26 (1): 1-6. 1994.
105.
Harri
Hemilä og R.M.Douglas: ”Vitamin C and
acute respiratory infections”. International Journal of Tuberculosis &
Lung Disease 3 (9): 756-761. 1999.
106.
Harri
Hemilä: ”Vitamin C supplementation and
common cold symptoms: factors affecting the magnitude of the benefit”.
Medical Hypothesis 52 (2): 171-178. Februar 1999.
107.
James Barton, Sharon M.McDonnell, Paul C. Adams, Pierre
Brissot, Lawrie W.Powell, Corwin Q.Edvards, James D.Cook og Kris V.Kowdley:
”Management of Hemochromatosis”. Annals of Internal Medicine 129 (11S):
932-939. 1998.
108.
Walter Henry: ”Echocardiographic Evaluation of the
Heart in Thalassemia Major”. Annals of Internal Medicine 91: 892-894. 1979.
109.
W.J.McCormick: ”Ascorbic Acid as a Chemotherapeutic
Agent”. Archives of Pediatrics 69: 151-155. 1952.
110.
O.S.Hoefel: ”Plasma Vitamin C Levels in Smokers” i
”Re-evaluation of Vitamin C”, utgitt av
A.Hanck. Hans Huber, Bern, 1977. Sidene
127-138.
111.
William Martindale og Kathleen Parfitt: ”The complete
drug reference”. Side 1365. 32. utgave, Pharmaceutical Press 1999. ISBN
0-85369-429-x.
112.
J.Lykkesfeldt, S.Christen, L.M.Wallock, H.H.Chang,
R.A.Jacob og B.B.Ames: ”Ascorbate is depleted by smoking and repleted by
moderate supplementation: a study in male smokers and nonsmokers with matched
dietary antioxidant intakes.” American Journal of Clinical Nutrition 71 (2):
530-6. 2000.
113.
S.J.Duffy,
N.Gokce, M.Holbrook, A.Huang, B.Frei, J.F.Keany Jr. og J.A.Vita: ”Treatment
of hypertension with ascorbic acid.” Lancet 354 (9195): 2048-9. 1999.
114.
P.E.Zollinger,
W.E.Tuinebreijer, R.W.Kreis og R.S.Breederveld: ”Effect of vitamin C on
frequency of reflex sympathetic dystrophy in Wrist fractures: a randomised
trial.” Lancet 354
(9195):2025-8. 1999.
115.
G.Block,
A.R.Mangels, B.H.Patterson, O.A.Levander, E.P.Norkus og P.R.Taylor, National
Cancer Institute, Bethesda, Maryland, USA: ”Body weight and prior depletion
affect plasma ascorbate levels attained on identical vitamin C intake: a
controlled-diet study.” Journal of the American College of Nutrition
18(6):628-37. 1999.
116.
C.G.Moertel,
T.R.Fleming, E.T.Creagan, J.Rubin, M.J.O’Connell og M.M.Ames: ”High-dose
vitamin C versus placebo in the treatment of patients with advanced cancer who
have had no prior chemoterapy. A randomized double-blind comparison.”
New England Journal of Medicine 312(3):137-41.
1985.
117.
J.A.Simon
og E.S.Hudes: ”Serum ascorbic acid and other correlates of self-reported
cataract among older Americans.” Journal of Clinical Epidemiology
52(12):1207-11. 1999.
118.
J.Zhang,
X.Ying, Q.Lu, A.Kallner, R.J.Xiu, P.Henriksson og I.Bjørkhem: ”A single
high dose of vitamin C counteracts the acute negative effect on
microcirculation induced by smoking a cigarette.” Microvascular Research
58(3):305-11. 1999.
119.
H.Tanaka,
T.Lund, H.Wiig, R.K.Reed, T.Yukioka, H.Matsuda og S.Shimazaki: ”High dose
vitamin C counteracts the negative interstitial fluid hydrostatic pressure and
early edema generation in thermally injured rats.” Burns 25 (7): 569-74.
1999.
120.
J.van
Rooij, S.G.Schwartzenberg, P.G.Mulder og S.G.Baarsma: ”Oral vitamins C and E
as additional treatment in patients with acute anterior uveitis: a randomised
double masked study in 145 patients.” British
Journal of Ophthalmology 83 (11):1277-82.
1999.
121.
R.J.Silverstein
og A.S.Landsman: ” The effects of a moderate and high dose of vitamin C on
wound healing in a controlled guinea pig model.” Journal of Foot & Ankle
Surgery 38(5): 333-8. 1999.
122.
Harri
Hemilä, J.Kaprio, P.Pietinen, D.Albanes
og O.P.Heinonen: ”Vitamin C and other compounds in vitamin C rich food in
relation to risk of tuberculosis in male smokers.” American Journal of
Epidemiology 150(6): 632-41. 1999.
123.
Mark Levine, Steven C.Rumsey, Rushad Daruwala, Jae B.Park
og Yaohui Wang: ”Criteria and Recommendations for Vitamin C Intake.” The
Journal of the American Medical Association 281(15): 1415-23.
1999.
124.
Alfred B. Ordman: ”Recommendations for Vitamin C Intake.”
The Journal of the American Medical Association 282(22): 2118-19.
1999.
125.
B.Brahma, R.E.Forman, E.E.Stewart, C.Nicholson og
M.E.Rice: ”Ascorbate inhibits edema in brain slices.” Journal of
Neurochemistry 74(3): 1263-70. 2000.
126.
L.C.Chapell,
P.T.Seed, A.L.Briley, F.J.Kelly, R.Lee, B.J.Hunt, K.Parmar, S.J.Bewley,
A.H.Shennan, P.J.Steer og L.Poston: ”Effect of antioxidants on the
occurrence of pre-ecklampsia in women at increased risk: a randomised
trial.” Lancet 354(9181):
810-6. 1999.
127.
A.Sakai,
T.Hirano, R.Okazaki, N.Okimoto, K.Tanaka og T.Nakamura: ”Large-dose ascorbic
acid administration suppresses the development of arthritis in
adjuvant-infected rats.” Archives of Orthopaedic & Trauma Surgery
119(3-4): 121-6. 1999.
128.
H.Tanaka,
T.Matsuda, Y.Miyagantani, T.Yukioka, H.Matsuda og S.Shimazaki: ”Reduction of
resuscitation fluid volumes in severely burned patients using ascorbic acid
administration: a randomized, prospective study.” Archives of Surgery
135(3): 326-31. 2000.
129.
B.Frei:
”Ascorbic Acid protects lipids in human plasma and low-density lipoprotein
against oxidative damage.” American Journal of Clinical Nutrition
54:1113S-8S. 1991.
130.
H.M.Zhang,
N.Wakisaka, O.Maeda og T.Yamamoto: ”Vitamin C inhibits the growth of a
bacterial risk factor for gastric carcinoma: Helicobacter pylori.” Cancer
80(10): 1897-903. 1997.
131.
N.H.Riordan,
H.D.Riordan, X.Meng, Y.Li og J.A.Jackson: ”Intravenous ascorbate as a tumor
cytotoxic agent.” Medical
Hypotheses 44(3): 207-13. 1995.
132.
J.Kadrabova,
A.Madaric og E.Ginter: ”Zinc and copper in the tissues and serum of cadmium
ontoxicated guinea-pigs: influence of vitamin C.” Physiological Research 42(4): 261-6. 1993.
133.
J.L.Freudenheim,
S.Graham, J.R.Marshall, B.P.Haughey og G.Wilkinson: ”A case controlled study
of diet and rectal cancer in Western New York.”
American Journal of Epidemiology 131(4): 612-24.
1990.
134.
C.J.Schorah,
A.Newill, D.L.Scott og D.B.Morgan: ”Clinical effects of vitamin C in elderly
inpatients with low blood-vitamin C-levels.”
Lancet 1(8113):403-5.
1979.
135.
M.Menon,
C.Maramag, R.K.Malhotra og L.Seethalakshmi: ”Effect of vitamin C on androgen
independant prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of
reactive oxygen species-effect on cell number, viability and DNA synthesis.”
Cancer Biochemistry Biophysics 16(1-2): 17-30.
1998.
136.
David
J.Hunter, JoAnn E.Manson, Graham A.Colditz, Meir J.Stampfer, Bernard Rosner,
Charles H.Hennekens, Frank E.Speizer og Walter C.Willett: ”A Prospective
Study Of The Intake of Vitamins C, E, And A, And The Risk Of Breast Cancer.”
The New England Journal of
Medicine 329(4): 234-40. 1993.
137.
N.Gokce,
J.F.Keaney Jr., B.Frei, M.Holbrook, M.Olesiak, B-J.Zachariah, C.Leeuwenburgh,
J.W.Heinecke og J.A.Vita: ”Long-term ascorbic acid administration
reverses endothelial vasomotor dysfunction in patients with coronary artery
disease.” Circulation 99(25):
3234-40. 1999.
138.
H.Gerster:
”High-dose vitamin C: a risk for persons with high iron stores?”
International Journal of
Vitamines Nutrition Res. 69(2): 67-82.
1999.
139.
C.S.Johnston:
” Biomarkers for establishing a tolerable upper intake level for vitamin
C.” Nutr. Rev. 57(3): 71-7. 1999
140.
K.A.Head:
”Ascorbic acid in the prevention and treatment of cancer.” Alternative
Medicine Review 3(3): 174-86. 1998.
141.
M.D.Wendt,
C.N.Soparkar, K.Louie, S.F.Basinger og R.L.Gross: ”Ascorbate stimulates type
I and III collagen in human Tenon’s fibroblasts.” J.Glaucoma 6(6): 402-7.
1997.
142.
H.F.Galley,
J.Thornton, P.D.Howdle, B.E.Walker og N.R.Webster: ”Combination oral
antioxidant supplementation reduces blood pressure.” Clin.Sci (Colch.) 92(4):
361-5. 1997.
143.
G.S.Omenn:
”Micronutrients (vitamins and minerals) as cancer-preventive agents.” IARC.
Sci. Publ. 139: 33-45. 1996.
144.
J.Eriksson
og A.Kohvakka: ”Magnesium and ascorbic acid supplementation in diabetes
mellitus.” Ann. Nutr. Metab. 39(4): 217-23.
1995.
145.
M.Jain,
A.B.Miller og T.To: ”Premorbid diet and the prognosis of woman with breast
cancer.” Journal of National Cancer Institute 86(18): 1390-7.
1994.
146.
C.H.Hennekens:
”Antioxidant vitamins and cancer.” American Journal of Medicine 97(3A):
2S-4S og 22S-28S. 1994.
147.
T.K.Basu:
”Vitamin C – aspirin interactions.” Int. J.Vitam.Nutr. Res.Suppl. 23:
83-90. 1982.
148.
Pressemelding
10.4.2000 fra National Academies Office of News and Public Information ved
Craig Hicks: ”Antioxidants’ Role in Chronic Disease Prevention Still
Uncertain; Huge Doses Considered Risky.”
149.
Owen
R.Fonorow, Vitamin C Foundation: ”Vitamin RDA’s Raised but Council
Cautions About Overdose.” April
2000.
150.
J.Lazarou,
B.Pomeranz og P.Corey: ”Incidence of Adverse Drug Reactions in Hospitalized
Patients.” Journal of the American Medical Association 15.4.1998, side 1200.
151.
”Why
Patients use Alternative Medicine.” Journal of the American Medical
Association 20.5.1998, sidene 1548-1553.
152.
M.Levine,
C.Conry-Cantlilena, Y.Wang, R.W.Welch og L.R.Cantlilena: ”Vitamin C
pharmacokinetics in healthy volunteers: evidence for a recommended dietary
allowance.” Proc. Natl. Acad. Sci. USA 1996;
93:3704-9.
153.
G.King,
M.Beins, J.Larkin, B.Summers og A.B.Ordman: ”Rate of excretion of vitamin C
in human urine.” AGE 1994; 17:87.
154.
H.E.Sauberlich:
”Pharmacology of vitamin C.” Ann.Rev.Nutr. 1994; 14:371.
155.
K.G.Losonczy,
T.B.Harris og R.J.Havlik: ”Vitamin E and vitamin C supplement use of
all-cause and coronary heart disease mortality in older persons; the
Established Populations for Epidemiologic Studies of the Elderly.”
Am.J.Clin.Nutr. 1996; 64:190.
156.
G.C.Curhan,
W.C.Willett, E.B.Rimm og M.J.Stampfer: ”A prospective study of the intake of
vitamins C and B6, and the risk of kidney stones in men.” J.Urol. 1996;
155:1847.
157.
M.N.Diaz,
B.Frei og J.A.Vita: ”Antioxidants and atherosclerotic heart disease.” New
England Journal of Medicine 1997; 337:408-16.
158.
C.J.Schorah:
”Vitamin C and gastric cancer prevention”, i R.Paoletti, H.Sies, J.Bug,
E.Grossi og A.Poli, utgivere av ”Vitamin C: The State of The Art in Disease
Prevention Sixty Years After the Nobel Prize.” Milano, Italia: Springer;
1998:41-9.
159.
P.Correa:
”Human gastric carcinogenesis.” Cancer Res. 1992; 52: 6735-40.
160.
R.Byers
og N.Guerrieri: ”Epidemiologic evidence for vitamin C and vitamin E in
cancer prevention.” Am. J. Clin. Nutr. 1995; 62(suppl): 1385S-1392S.
161.
J.T.Vanderslice
og D.J.Higgs: ”Vitamin C content of foods.” Am.J.Clin.Nutr. 1991; 54 (suppl):
1323S-1327S.
162.
J.W.Erdman
og B.P.Klein: ”Harvesting, processing, and cooking influences on vitamin C
in foods” i P.A.Seib og B.M.Tolbert utgivere av ”Ascorbic Acid: Chemistry,
Metabolism, and Uses.” Washington DC: American Chemical Society; 1982:
533-550.
163.
L.C.Yong,
C.C.Brown og A.Schatzkin: ”Intake of vitamins E, C and A and risk of lung
cancer.” Am.J. Epidemiol. 1997; 146: 231-43.
164.
T.Byers
og J.Mouchawar: ”Antioxidants and cancer prevention in 1997” i R.Paoletti,
H.Sies, J.Bug, E.Grossi og A.Poli, utgivere av ”Vitamin C: The State of The
Art in Disease Prevention Sixty Years After the Nobel Prize.” Milano,
Italia: Springer; 1998:29-40.
165.
D.Hornig:
”Distribution of ascorbic acid, metabolites and analogues in man and
animals.” Ann.
NY Acad. Sci. 1975; 258:103.
166.
Gladys
Block, National Cancer Institute, og Marilyn Menkes, The John Hopkins School
of Hygiene and Public Health: ”Ascorbic Acid in Cancer Prevention”,
publisert i boken redigert av Thomas E.Moon, University of Arizona, og Marc
S.Micozzi, Armed Forces Institute of Pathology, utgitt av Marcel Dekker, Inc.,
New York, 1989. Sidene 341 – 388.
167.
B.Hofstad,
K.Almendingen, M.Vatn, S.N.Andersen, R.W.Owen, S.Larsen og M.Osnes: ”Growth
and recurrence of colorectal polyps: a double-blind 3-year intervention with
calcium and antioxidants.” Digestion
1998;59(2):148-56.
